1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Novateor Research Laboratories

Novateor Research Laboratories

NOVATEOR.BO
Novateor Research LaboratoriesIN flagBombay Stock Exchange
32.85
INR
+0.20
- -
198.81MMarket Cap
Novateor Research Laboratories
NOVATEOR.BO
(Bombay Stock Exchange)

Recent

price

32.85

P/E

ratio

- -

div

yld

- -

ROIC.AI

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
0.28
0.18
0.84
1
0.32
1.53
2.61
2.5
5.77
- -
Revenue per Share
-0.01
- -
0.45
-0.02
0.02
-0.47
0.08
0.06
0.17
- -
Basic EPS, GAAP
0.02
0.11
-0.15
-8.66
-0.45
-2.84
-2.74
-3.54
-3.58
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
0.01
- -
- -
- -
Dividend per Share
0.08
0.08
6.56
12.76
8.55
9.92
10.05
10.11
10.33
- -
Book Value per Share
1.91
1.92
8.43
21.7
14.53
16.14
16.3
18.13
21.91
- -
Tangible Book Value per Share
5
5
5
4
6
5
5
5
5
- -
Basic Weighted Avg Shares
1
1
4
4
2
7
13
12
28
38
Sales/Revenue/Turnover
-7.65
-18.65
47.1
-59.12
-226.75
-36.66
-31.79
-30.88
-10.49
-7.56
Operating Margin (%)
1
1
1
1
1
1
1
1
2
2
Depreciation Expense
- -
- -
2
- -
- -
-2
- -
- -
1
1
Net Income, GAAP
203.33
44.44
26
129.69
28.69
- -
7.26
36.72
27.74
10.93
Effective Tax Rate (%)
-2.18
1.03
53.57
-2
6.29
-30.79
2.91
2.43
2.95
2.64
Profit Margin (%)
1
2
5
51
54
61
58
63
75
86
Working Capital
8
8
- -
1
2
2
3
5
4
3
LT Debt
9
9
41
86
86
78
79
88
105
115
Total Equity
- -
-0.5
4.78
1.07
-3.47
- -
-4.43
-2.54
-1.97
-2.15
Return on Invested Capital (%)
- -
0.55
10.92
-0.19
0.23
- -
0.78
0.81
2.24
2.74
Return on Capital (%)
- -
2.26
13.6
-0.19
0.23
-4.63
0.76
0.6
1.66
1.84
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
6.52%
9.13%
Free Cash Flow
- -
71.39%
-88.31%
Net Income, GAAP
- -
-393.71%
23.72%
Sales/Revenue/Turnover
- -
105.74%
37.81%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
12
2025
- -
- -
- -
- -
28
2026
- -
- -
- -
- -
38

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.06
2025
- -
- -
- -
- -
0.17
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Nyxoah S.A. (NYXH)
Ypsomed Holding AG (YPSN.SW)
Assure Tech (Hangzhou) Co., Ltd. (688075.SS)
Aurinia Pharmaceuticals Inc. (AUP.TO)
Gencurix, Inc. (229000.KQ)
Japan Eyewear Holdings Co., Ltd. (5889.T)
Business
Novateor Research Laboratories Ltd (NOVATEOR.BO) develops, manufactures and markets novel personal care products focused on oral care in India. The company offers teeth whitening strips, whitening toothpaste, whitening toothbrushes, charcoal gel strips, tongue cleaners, denture products, mouthwashes and rinses, dental accessories and prosthesis cleaning solutions, primarily under the SmiloShine brand; all products undergo FDCA approval for clinical and commercial use. It sells through dentists, cosmetic parlors, modern retailers, distributors and online platforms including Amazon, Flipkart and Nykaa, with primary operations in Gujarat and Maharashtra from its manufacturing facility in Sanand Taluka, Ahmedabad District. Founded in 2011 and headquartered at 1026 Dev Atelier, Opp. Dev Aurum, Anandnagar Cross Road, Prahladnagar, Ahmedabad, Gujarat, the company converted from private limited to public limited status in April 2019 ahead of its SME IPO listing on BSE. Recent developments include the appointment of Anil Tilakraj Arora as additional independent director on September 3, 2025, pending shareholder regularization at the 14th AGM on September 30, 2025; reappointment of secretarial and internal auditors for FY2025-26; and additions to memorandum of association business objects, alongside sustained sales growth to Rs 2.92 crore and net profit of Rs 0.08 crore for FY2025.